ZA200805108B - Treatment of neurodegenerative disorders - Google Patents
Treatment of neurodegenerative disordersInfo
- Publication number
- ZA200805108B ZA200805108B ZA200805108A ZA200805108A ZA200805108B ZA 200805108 B ZA200805108 B ZA 200805108B ZA 200805108 A ZA200805108 A ZA 200805108A ZA 200805108 A ZA200805108 A ZA 200805108A ZA 200805108 B ZA200805108 B ZA 200805108B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatment
- neurodegenerative disorders
- neurodegenerative
- disorders
- Prior art date
Links
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
- C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0524023A GB2432586B (en) | 2005-11-25 | 2005-11-25 | Treatment of neurodegenerative disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200805108B true ZA200805108B (en) | 2009-03-25 |
Family
ID=35601208
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200805108A ZA200805108B (en) | 2005-11-25 | 2008-06-11 | Treatment of neurodegenerative disorders |
Country Status (13)
Country | Link |
---|---|
US (1) | US20090221513A1 (fr) |
EP (1) | EP1959980A2 (fr) |
JP (1) | JP2009517376A (fr) |
CN (1) | CN101351214A (fr) |
AR (1) | AR058532A1 (fr) |
AU (1) | AU2006318834A1 (fr) |
BR (1) | BRPI0618994A2 (fr) |
CA (1) | CA2630922A1 (fr) |
GB (1) | GB2432586B (fr) |
IL (1) | IL191681A0 (fr) |
MX (1) | MX2008006773A (fr) |
WO (1) | WO2007060486A2 (fr) |
ZA (1) | ZA200805108B (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5634062B2 (ja) * | 2009-12-28 | 2014-12-03 | カルピス株式会社 | 脳機能改善用組成物および脳機能を改善する方法 |
JP5643624B2 (ja) * | 2010-12-03 | 2014-12-17 | 日本サプリメント株式会社 | 記憶増強剤および記憶力を増強する方法 |
JP5755436B2 (ja) * | 2010-12-03 | 2015-07-29 | 日本サプリメント株式会社 | 記憶増強剤および記憶力を増強する方法 |
WO2014076709A1 (fr) * | 2012-11-19 | 2014-05-22 | Technion Research And Development Foundation Ltd. | Liposomes pour distribution in vivo |
GB201613999D0 (en) * | 2016-08-16 | 2016-09-28 | Neuro-Bio Ltd | Neurodegenerative disorders |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0680079B2 (ja) * | 1984-11-09 | 1994-10-12 | エーザイ株式会社 | ポリペプチド |
GB9917725D0 (en) * | 1999-07-28 | 1999-09-29 | Medical Res Council | Peptides |
EP2228388A1 (fr) * | 2001-04-18 | 2010-09-15 | The Open University | Polypeptides protégés Arg-Glu-Arg et leurs utilisations |
US7491702B2 (en) * | 2001-04-18 | 2009-02-17 | The Open University | Polypeptides related to amyloid precursor protein, pharmaceutical compositions thereof, and methods of treatment using the same |
US7622446B2 (en) * | 2001-04-18 | 2009-11-24 | The Open University | Polypeptides, derivatives and uses thereof |
WO2004028548A2 (fr) * | 2002-09-26 | 2004-04-08 | Carbomer, Inc. | Agents neuroprotecteurs |
-
2005
- 2005-11-25 GB GB0524023A patent/GB2432586B/en not_active Expired - Fee Related
-
2006
- 2006-11-24 BR BRPI0618994-6A patent/BRPI0618994A2/pt not_active IP Right Cessation
- 2006-11-24 EP EP06808778A patent/EP1959980A2/fr not_active Withdrawn
- 2006-11-24 AU AU2006318834A patent/AU2006318834A1/en not_active Abandoned
- 2006-11-24 CN CNA2006800501969A patent/CN101351214A/zh active Pending
- 2006-11-24 AR ARP060105199A patent/AR058532A1/es unknown
- 2006-11-24 WO PCT/GB2006/050414 patent/WO2007060486A2/fr active Application Filing
- 2006-11-24 US US12/085,480 patent/US20090221513A1/en not_active Abandoned
- 2006-11-24 JP JP2008541834A patent/JP2009517376A/ja active Pending
- 2006-11-24 MX MX2008006773A patent/MX2008006773A/es not_active Application Discontinuation
- 2006-11-24 CA CA002630922A patent/CA2630922A1/fr not_active Abandoned
-
2008
- 2008-05-25 IL IL191681A patent/IL191681A0/en unknown
- 2008-06-11 ZA ZA200805108A patent/ZA200805108B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
GB0524023D0 (en) | 2006-01-04 |
JP2009517376A (ja) | 2009-04-30 |
GB2432586A (en) | 2007-05-30 |
CN101351214A (zh) | 2009-01-21 |
IL191681A0 (en) | 2009-02-11 |
EP1959980A2 (fr) | 2008-08-27 |
WO2007060486A2 (fr) | 2007-05-31 |
BRPI0618994A2 (pt) | 2011-09-20 |
MX2008006773A (es) | 2009-01-21 |
AU2006318834A1 (en) | 2007-05-31 |
WO2007060486A3 (fr) | 2007-09-07 |
US20090221513A1 (en) | 2009-09-03 |
AR058532A1 (es) | 2008-02-06 |
CA2630922A1 (fr) | 2007-05-31 |
GB2432586B (en) | 2010-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL208607A0 (en) | Improved nanobodiestm for the treatment of aggregation-mediated disorders | |
EP1861126A4 (fr) | Traitement de troubles lies a la degradation de proteines | |
ZA200707280B (en) | Treatment of bone disorders | |
PL1890684T3 (pl) | Leczenie zaburzeń snu i czuwania | |
IL188204A0 (en) | Combination therapy for the treatment of immunoinflammatory disorders | |
IL191283A (en) | Compositions for treating eye irregularities | |
ZA200809528B (en) | Treatment for depressive disorders | |
EP2004204A4 (fr) | Traitement de maladies neurodegénératives | |
ZA200803440B (en) | Compounds for the treatment of metabolic disorders | |
ZA200809527B (en) | Treatment for depressive disorders | |
HK1157575A1 (en) | Treating neurological disorders | |
IL190652A0 (en) | Novel pharmaceutical combinations for the treatment of respiratory disorders | |
IL177955A0 (en) | Sulfonamide compounds for the treatment of neurodegenerative disorders | |
ZA200806455B (en) | Use of 2-imidazoles for the treatment of CNS disorders | |
GB0610183D0 (en) | Treatment of neurodegenerative diseases | |
IL187439A0 (en) | Compounds useful for treating neurodegenerative disorders | |
IL193799A0 (en) | New therapeutic combinations for the treatment or prevention of psycotic disorders | |
ZA200805108B (en) | Treatment of neurodegenerative disorders | |
ZA200802270B (en) | Treatment of neurodegenerative disorders | |
IL192877A0 (en) | Use of 2-imidazoles for the treatment of cns disorders | |
GB0809476D0 (en) | Treatment of neurodegenerative disorders | |
GB0519274D0 (en) | The treatment of neurodegenerative diseases | |
EP2212246B1 (fr) | Traitement de troubles neurologiques | |
ZA200807678B (en) | Meridamycin analogues for the treatment of neurodegenerative disorders | |
GB0410846D0 (en) | Treatment of neurodegenerative conditions |